This inventor holds 24 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Agenus Inc., Ludwig Institute for Cancer Research Limited, Memorial Sloan Kettering Cancer Center. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
22 out of 53 
16 out of 530 
16 out of 621 
Years Active: 2018-2025
Areas of Expertise:
Title: The Inventive Journey of David Adam Savitsky
Introduction: David Adam Savitsky, a prolific inventor based in Boxford, MA, has made significant contributions to the field of biomedicine, specifically in the development of innovative antibodies. With a remarkable portfolio of 22 patents, his work is at the forefront of medical research and treatment methodologies.
Latest Patents: Among his latest patents are groundbreaking developments focusing on antibody therapies. One such patent is for "Anti-CTLA-4 antibodies and methods of use thereof," which discloses antibodies that specifically bind to CTLA-4 (particularly human CTLA-4) and inhibit its function. The patent also includes pharmaceutical compositions comprising these antibodies along with nucleic acids, expression vectors, and host cells for their production, as well as outlining methods for treating subjects with these antibodies. Another notable patent is for "Anti-LAG-3 antibodies and methods of use thereof," which describes antibodies that specifically bind to LAG-3, antagonizing its function as well. Like the previous patent, it provides comprehensive detail on related pharmaceutical compositions, nucleic acids, and treatment methods.
Career Highlights: David has held key positions in prominent organizations including Agenus Inc. and Memorial Sloan Kettering Cancer Center. His roles in these companies have allowed him to advance his research and translate his inventive ideas into valuable therapeutic solutions.
Collaborations: Throughout his career, David has collaborated with noteworthy professionals in the field, such as Nicholas Stuart Wilson and David Schaer. These partnerships have likely contributed to his innovative approach and the successful development of his patents.
Conclusion: David Adam Savitsky’s contributions to the field of biomedical innovation are evident through his extensive patent portfolio and collaborative efforts. His focus on antibody development stands to make a significant impact on future medical treatments, showcasing the importance of continuous innovation in biomedicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile